|Bid||0.0050 x N/A|
|Ask||0.0060 x N/A|
|Day's range||0.0050 - 0.0050|
|52-week range||0.0040 - 0.0180|
|Beta (5Y monthly)||1.73|
|PE ratio (TTM)||∞|
|Earnings date||29 Sept 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
AXP Energy Limited (ASX: AXP, OTC US: AUNXF), ('AXP', 'Company') provides this summary of activities for the quarter ended 30 June 2022 (all in USD unless stated otherwise).
SOUTH SAN FRANCISCO, Calif., May 03, 2022--iSono Health, Inc. today announced U.S. FDA clearance of the company’s ATUSA™ System for breast imaging.
AXP Energy Limited (ASX: AXP, OTC US: AUNXF), ('AXP', 'Company') announces its assessment of Reserves and Contingent Resources as at 1 October 2021. The Reserves and Resources below are net to AXP unless stated otherwise. They include, for the first time, the Reserves and Resources gained with the acquisitions of Appalachian Basin asset (MHP) and the new Illinois Basin asset (Trey Exploration).